Skip to main content
. 2019 Jan 8;27(2):483–493. doi: 10.1016/j.jfda.2018.12.008

Fig. 3.

Fig. 3

Comparison of LRG1/total protein levels of the oral cancer validation group across normal cases and different cancer stages. (A) LRG1/total protein levels in plasma. (B) LRG1/total protein levels divided by levels of total protein in plasma. (C) The ROC curve and diagnostic performance of LRG1/total proteins in the validation group.